Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-3816

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-3816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636293816

Label for Oxcarbazepine 150 mg film-coated tablets by Bryant Ranch Prepack, highlighting a comparison to Trileptal 150MG tablets by Nexgen Pharma. The label includes packaging details, an NDC number 63629-3816, and storage instructions to keep at room temperature 20°-25°C (68°-77°F) with a safety warning to keep drugs out of reach of children.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine depicted as a molecular diagram showing its ring system with a ketone and an amide group attached to a tricyclic framework.*

FDA Label Image

Chemical Structure (Oxcarbazepine 02)

A Kaplan-Meier exit rate curve graph comparing Oxcarbazepine and placebo treatment groups over a 9-day trial period starting from Day 2 at 8 am. The x-axis shows time on trial in days, and the y-axis shows exit rate from 0.0 to 1.0. The graph includes a log-rank test p-value = 0.0001, indicating statistical comparison between groups.*

FDA Label Image

Chemical Structure (Oxcarbazepine 03)

A Kaplan-Meier plot depicting seizure rate over time from first dose to first seizure. The x-axis shows days (0 to 140) and the y-axis shows seizure rate (0 to 1.0). Two treatment groups are compared: Oxcarbazepine (solid line) and Placebo (dotted line). A log-rank test p-value of 0.046 is displayed on the graph.*

FDA Label Image

Chemical Structure (Oxcarbazepine 04)

A Kaplan-Meier survival curve chart showing exit rate over time to exit (days) for two treatment groups labeled HIGH and LOW. The curve for the LOW treatment group rises more steeply, reaching near 1.0 exit rate faster than the HIGH group. A log-rank test p-value of 0.0001 is displayed, indicating statistical comparison between groups.*

FDA Label Image

Chemical Structure (Oxcarbazepine 05)

A Kaplan-Meier survival curve graph showing the exit rate over time (days) for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days, and the y-axis represents the exit rate from 0 to 1. The LOW group curve is dotted and rises faster than the solid HIGH group curve. A log-rank test p-value of 0.0001 is noted on the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.